- Home
- HY vs ZVRA Comparison
HY vs ZVRA Comparison
Compare HY & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HY | ZVRA |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.5M | 499.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HY | ZVRA |
|---|---|---|
| Price | $32.60 | $8.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.71 |
| AVG Volume (30 Days) | 141.4K | ★ 912.1K |
| Earning Date | 02-24-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.15 | ★ 0.54 |
| Revenue | ★ $3,913,600,000.00 | $84,388,000.00 |
| Revenue This Year | N/A | $333.25 |
| Revenue Next Year | N/A | $43.70 |
| P/E Ratio | $206.55 | ★ $15.52 |
| Revenue Growth | N/A | ★ 244.60 |
| 52 Week Low | $26.41 | $6.19 |
| 52 Week High | $57.89 | $13.16 |
Technical Indicators
Market Signals| Indicator | HY | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 56.70 | 42.80 |
| Support Level | $28.83 | $8.21 |
| Resistance Level | $31.20 | $9.02 |
| Average True Range (ATR) | 1.20 | 0.35 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 77.73 | 32.18 |
Price Performance
Historical ComparisonAbout HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.